CNE000000BG1
CNE000000BG1
XINHUA PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 8.754.721.988 | 8.466.309.803 | 3.4% |
| Cost of Revenue | 7.110.179.627 | 6.424.760.722 | 10.7% |
| Gross Profit | 1.644.542.361 | 2.041.549.081 | 19.4% |
| 1.202.993.881 | 1.445.217.885 | 16.8% | |
| Operating Income | 441.548.480 | 596.331.197 | 26.0% |
| Pretax Income | 358.916.503 | 533.653.423 | 32.7% |
| Net Income Common Stockholders | 289.888.855 | 470.023.746 | 38.3% |
| -- | -- | -- | |
| -- | -- | -- |